Yakup Ergün @dr_yakupergun
Medical Oncologist / Antalya City Hospital Exploring Evidence-Based Approaches in Cancer | Equality in Oncology Care Türkiye Joined December 2012-
Tweets1K
-
Followers2K
-
Following319
-
Likes5K
The evolving treatment landscape of metastatic urothelial cancer A great review on urothelial cancers, where the significant developments in terms of survival have occurred in recent times👇 @OncoAlert @NatRevUrol nature.com/articles/s4158…
Thank you very much to everyone who contributed by voting and commenting. 💥A large majority chose to treat ER-Low/HER2- BC like TNBC. 🔍ER-low BC accounts for about 2% of all breast cancers. According to intrinsic subtype analyses, approximately 80% of ER-Low tumors are…
Thank you very much to everyone who contributed by voting and commenting. 💥A large majority chose to treat ER-Low/HER2- BC like TNBC. 🔍ER-low BC accounts for about 2% of all breast cancers. According to intrinsic subtype analyses, approximately 80% of ER-Low tumors are…
Targeting the EGFR signalling pathway in metastatic colorectal cancer An excellent review👇 @LancetGastroHep thelancet.com/journals/langa…
#bcsm case 58-year-old postmenopausal Denovo multiple bone and solitary liver mets Pathology: IDC, ER 5%, PR-, HER2-, Ki67 40%, PD-L1 20% Intrinsic subtype unknown What systemic treatment would you recommend in the first-line? Your opinion on ER-Low/HER2- BC would be very…
USPSTF Recommendation: Screening for Breast Cancer 💥The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. 💥For those aged 75 and over, the evidence is insufficient @OncoAlert @JAMA_current jamanetwork.com/journals/jama/…
Alternative approaches to risk–benefit balancing in immunotherapy 🔹️Are proactive approaches like prophylactic tocilizumab appropriate to reduce side effects? 🔹️We know that there isn't a linear dose-response relationship in anti-PD1 and anti-PDL1 therapies, so can we…
FDA approves tisotumab vedotin-tftv for recurrent/metastatic cervical cancer. 🔘Major trial shows median OS of 11.5 months vs 9.5 with chemotherapy, PFS at 4.2 vs 2.9 months. ORR is 17.8% vs 5.2%. 🔘Watch for neuropathy & low hemoglobin. 🔘Don't forget, HPV vaccine is key…
Completely agree with our @OncoAlert 🚨Faculty @BenWestphalen 🇩🇪 We have been seeing the same with the emergence of new accounts that are NOT adding to the conversation but rather are the same echo chambers we have been avoiding in Oncology SoMe OncoAlert has always been and…
Completely agree with our @OncoAlert 🚨Faculty @BenWestphalen 🇩🇪 We have been seeing the same with the emergence of new accounts that are NOT adding to the conversation but rather are the same echo chambers we have been avoiding in Oncology SoMe OncoAlert has always been and…
In the treatment of breast cancer, a multidisciplinary approach is essential. It should not be an option but a necessity for patients to be evaluated by a medical oncologist before undergoing surgery.
In the treatment of breast cancer, a multidisciplinary approach is essential. It should not be an option but a necessity for patients to be evaluated by a medical oncologist before undergoing surgery.
📢 Alert🚨🚨🚨 ✅FDA granted "traditional" approval to tisotumab vedotin for recurrent or metastatic cervical cancer with progression on or after chemotherapy!!! @OncoAlert @DrYukselUrun @dr_yakupergun @Erman_Akkus @coskunyazgann #cervical #Cancer
Dear Colleagues, One Month until #ASCO24 🌐 WE ARE READY WE ARE @OncoAlert 🚨 #OncoAlertAF @nataliagandur 🇦🇷 @acampsmalea 🇫🇷 @MartaPerachino 🇮🇹 @heinrich_kat 🇩🇪 @BiagioRicciutMD 🇺🇸 @DenizCanGuven1 🇹🇷 @yekeduz_emre 🇺🇸 @HHorinouchi 🇯🇵 @FadiHaddad_MD 🇺🇸 @Dr_Ivanoncologo 🇲🇽…
10 reasons why T-DXd can be effective for treating HER2-0 breast cancer from 1.5 yrs ago All still valid 🧵👇
10 reasons why T-DXd can be effective for treating HER2-0 breast cancer from 1.5 yrs ago All still valid 🧵👇
New definition: HER2-UltraLow With repeat biopsies, we will always find HER2, even if it's very faint. The time has come for this question: do we really need HER2 positivity for T-DXd in the subsequent line?
New definition: HER2-UltraLow With repeat biopsies, we will always find HER2, even if it's very faint. The time has come for this question: do we really need HER2 positivity for T-DXd in the subsequent line?
Really feel like we don't need to be testing for HER-2 for TDXd in #bcsm: 1) IHC testing isn't that good 2) HER-2 is so heterogeneous biopsy to biopsy 3) other ADCs we don't test (TROP, HER-3 etc). Only b/c it was "HER-2" did we get stuck in this testing algorithm to begin with!
Really feel like we don't need to be testing for HER-2 for TDXd in #bcsm: 1) IHC testing isn't that good 2) HER-2 is so heterogeneous biopsy to biopsy 3) other ADCs we don't test (TROP, HER-3 etc). Only b/c it was "HER-2" did we get stuck in this testing algorithm to begin with!
NEWS FROM INDUSTRY Results from the DESTINY-Breast06 trial indicate that trastuzumab deruxtecan🧪could become a new standard of care for #HER2 -low 🧬and HER2-ultralow metastatic #BreastCancer patients ➡️showing significant PFS improvements 📈over standard chemotherapy after…
THE @OncoAlert 🚨5K REGISTRATION at #ASCO24 Saturday, June 1st at 7am (Chicago) Start Hyatt Regency at McCormick Place , Chicago Countries of Colleagues participating: 🇺🇸🇨🇦🇨🇭🇹🇷🇮🇹🇧🇪🇸🇪🇲🇽🇱🇧🇵🇹🇫🇷🇲🇦🇦🇹🇭🇺🇸🇰🇮🇳🇩🇪🇮🇪🇳🇿🇬🇭🇪🇸🇪🇸🇻🇳🇳🇵 oncoalert.m-pages.com/T8RKPR/the-onc… A warm welcome to our…
A great review about the present and future of tumor-agnostic treatments👇 @OncoAlert cancertreatmentreviews.com/article/S0305-…
🩸New ASH guidelines on VTE in cancer patients: Strongly recommend LMWH for initial VTE treatment. Thromboprophylaxis advised for high-risk cases but not for low-risk chemotherapy patients. #VTE #CancerCare #ASH @aakonc @gary_lyman @Cihan_Ay_MD @ASH_hematology @BloodAdvances…
Yüksel Ürün @DrYukselUrun
6K Followers 574 Following Prof. Medical Oncologist 🔬 @AnkaraUni 🎓 Advocate for #Diversity & #Equity 🌟 Genitourinary Cancer I 2023-2024 @ASCO Leadership Development Program
Oncology Brothers @OncBrothers
12K Followers 414 Following Practice changing 🗣 by community oncologists: Rohit Gosain @RoswellPark & Rahul Gosain @WilmotCancer. OwnViews & not medical advice.COI https://t.co/cJOjp0RvQE
Paolo Tarantino @PTarantinoMD
22K Followers 536 Following Medical Oncologist, Research Fellow @DanaFarber | @Harvard | PhD @LaStatale. SoMe Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs & good music.
Deniz Can Guven @DenizCanGuven1
2K Followers 1K Following Medical Oncologist @myESMO Young Oncologist Committee Member Editorial Board Member in @BMC Cancer, @PLOSONE, @thePeerJ, and @OfOncological
Nazli Dizman @NazliDizman
8K Followers 6K Following MD & Researcher | Heme/Onc fellow @MDAndersonNews | @YaleIMed ‘23 | Postdoc @cityofhope @montypal | @ASCOTECAG | #WomenInMedicine | T/RT my own
Pashtoon Kasi MD, MS @pashtoonkasi
18K Followers 11K Following Oncologist | Researcher | ColorectalCancer #CRCSM👨🏼🎓@MayoClinic @PittTweet Alum; 🧬#ctDNA #LiquidBiopsies💡#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO23
Mark Lewis @marklewismd
88K Followers 39K Following Director, GI Oncology, @Intermountain. Interests: neuroendocrine tumors, cancer syndromes, empathy (even had a Whipple myself). Tweets my own.
Erika Hamilton, MD @ErikaHamilton9
15K Followers 3K Following Med Onc, Director of Breast Cancer Research Program @ Sarah Cannon Research Institute #bcsm #WomenInMedicine Wife, Mom to 2 girls, tweets are mine.
Dr Amol Akhade @SuyogCancer
3K Followers 122 Following Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists
Doç.Dr.Erdinç Nayı.. @dronkoloji
9K Followers 2K Following Tıbbi Onkoloji Uzmanı / VM Medicalpark Mersin Hastanesi /Mail: [email protected]
Emre Yekedüz @yekeduz_emre
2K Followers 974 Following MD, Medical Oncologist I Research Fellow @DanaFarber_GU @Harvard | @ASCO #IMG CoP Comm Team Member| Assoc. Faculty @OncoAlert | Alumni @AnkaraUni @Hacettepe1967
Ibrahim Halil SAHIN, .. @IbrahimSahinMD1
3K Followers 733 Following GI Medical Oncologist | @UPMC Hillman CC/@PittTweet | NCI Colon Task Force | Clinical trialist-Colorectal Cancer| EO-CRC|musician-lead guitar| tweets=my own
Doç.Dr.Cengiz Karaç.. @KaracinCengiz
1K Followers 1K Following Türk Tıbbi Onkoloji Derneği Yönetim Kurulu Üyesi
Razelle Kurzrock, MD @Dr_R_Kurzrock
7K Followers 5K Following Momx7 (4 children; 3 dogs); wife; Precision/Rare diseases; MCW AD; CMO WIN; physician, not provider; Board CureMetrix/CureMatch (cofounder); opinions mine
Enrique Grande @drenriquegrande
10K Followers 7K Following Jefe del Servicio de #Oncología Médica y Director de Investigación Clínica de la Fundación MD Anderson Cancer Center Madrid. Opinions are my own
Andres F. Cardona @AndresFCardonaZ
8K Followers 4K Following Pursue knowledge, mentor students, collaborate globally, and push boundaries. Everything else is just noise in the academic concert.
Ömer Dizdar @dromerdizdar
837 Followers 510 Following Medical Oncology & Cancer Epidemiology, Cancer Institute, Hacettepe University #ESMO #EORTC GI & Melanoma Group #Colorectalcancer #Gastriccancer
Alessandra Forcina @AlessandraForc3
5 Followers 44 Following
berkay şimşek🌻 @simsek_berkay_
90 Followers 176 Following MD, Pathologist, Current Postdoctoral Research Fellow @BrighamWomens Pathology | Signorettli Lab | Gazi Patoloji, 2024 | Hacettepe Tıp 2019
Therapeutics Initiati.. @Drug_Evidence
7K Followers 4K Following UBC-based, independent, evidence-informed, practical #BetterPrescribing information for #Physicians, #NursePractitioners, #Pharmacists #MedEd #CME RT≠endorse
bahramçubin @Veysielebi86336
0 Followers 97 Following
Marta Perachino @MartaPerachino
440 Followers 242 Following MD | Medical Oncology Resident @ Policlinico San Martino ✈️ Research fellow @ Vall d’Hebron Institute of Oncology
Zoran Petrović @Zoran0414
45 Followers 343 Following I am a clinical oncologist. My main field of work is gastrointestinal oncology.
Chiquillos @chiquilloss
47 Followers 468 Following Gerçek sosyalizm İslam'dır.Komşun açken sen tok yatamazsın
Yağmur Simge Sağlam @YagmursSaglam
45 Followers 62 Following Karadeniz Teknik Üniversitesi İnşaat Mühendisliği
Mir Efsun @mirefsun
12 Followers 401 Following
Kavitha Gangineni @KavithaTP31
8 Followers 413 Following
Leandro Apolinario da.. @LeandroApolin12
75 Followers 175 Following MD, Clinical Oncology, Researcher, Recife, Brazil.
John L. @MeeomHealthClub
3K Followers 4K Following R&D @ MEEOM® the Fastest Growing #PrecisionMedicine Charity that heals #Stroke #Cancer & cures #ADHD #ASD #COPD #COVID #HBV #HCV #FLD #OSA …
Manel Dhaoui @mdhaoui2020
10 Followers 199 Following
artline76 @artline76
0 Followers 110 Following
Maritza @MaritzaNotBot
333 Followers 4K Following
World Journal of Onco.. @WJON_Journal
3K Followers 707 Following PubMed/PubMed Central/Scopus/EMbase/Web of Science (ESCI) indexed, JCR Impact Factor 2022: 5.2. Editor-in-Chief: Prof. Kazuaki Takabe, New York, USA
Dazhi Liu, Pharm.D, B.. @dazhiliurx
228 Followers 399 Following opinions are my own. Clinical Pharmacy Specialist - Early Drug Development- Memorial Sloan Kettering Cancer Center
Sarah Weller @_sarahweller
3K Followers 2K Following Finding ways to impact cancer care globally, innovate, and improve outcomes. Role: Global Director, Prostate Cancer @ Movember. Views = mine.
Nobuhiro Shibata@走�.. @shibanob
136 Followers 252 Following Medical Oncologist/走る腫瘍内科医/関西医科大学附属病院がんセンター所属/フルマラソンPB 3時間24分50秒・2019年延岡西日本/日本臨床腫瘍学会 がん薬物療法専門医・指導医/専門は乳がん・消化器がん/個別相談はご遠慮ください/発言は所属を代表するものではありません
Hana Studentova @HStudentova
4 Followers 129 Following
Kay Walz @KayWalz51148
62 Followers 201 Following
Ali Almufti FACS FICM.. @alimomtazmufti
416 Followers 3K Following General Surgeon. Iraqi Board certified. Trainee at Bariatric and Metabolic surgery Fellowship. Member of SAGES, EAES.
Elif Burkan @ElifBurkan
426 Followers 883 Following
Jennifer Cortes @jenycort
32 Followers 112 Following
Dr Sarah Sammons @drsarahsam
4K Followers 1K Following Breast Medical Oncologist @dfci_breastonc. Harvard Medical School. Associate Director EMBRACE MBC Program. Tweets are NOT medical advice.
Saleh Javaher @SalehJavaher
17 Followers 99 Following Biotechnology MSc Graduate | Interested In Cancer Research with a Focus on ADCs
SAAD Mohammed Amine @Mohammed_AmineS
2 Followers 82 Following
Gianpiero Rizzo, MD @gianpiero_rizzo
17 Followers 123 Following Medical Oncologist at San Matteo of Pavia #breastcancer
RAD @RupDixit
6 Followers 101 Following
Cristiana Marques @Cristia33110684
3 Followers 46 Following
Colt Egelston @ColtEgelston
298 Followers 1K Following Immuno-Oncology at City of Hope. Lover of beagles and a long run.
Dámaris Intriago �.. @DamarisIntriago
7K Followers 6K Following Professor in Cell and Molecular Biology & Researcher in Molecular Oncology and Public Health at @UISEK | 👩🎓: @ImperialMed 🇬🇧 & #USFQ 🇪🇨 | 🇺🇸🇩🇪🇲🇽
Hiba Ali @hiba_g_ali
196 Followers 1K Following Pharmacist | Patient Advocate | Oncology Medical Science Liaison @Astrazeneca | Ex @Roche @GileadSciences #Oncology #Hematology #PrecisionMedicine |
Wing F. Li @WFDr19
80 Followers 244 Following PGY 0 | Jacobi Medical Center | MD @Tsinghua_uni | Researcher | Educator
Kim @_kimberlybarry
21 Followers 878 Following
Park, Jookyung Sophie.. @MDSOPHIE
32 Followers 84 Following Gastroenterologist, https://t.co/WD7pvCONfk.D, Specialized in Pancreatobiliary Tract Diseases Samsung Medical Center, Sungkyunkwan University School of Medicine
Ricardo Amorín @RSIAmorin
13 Followers 79 Following Oncologo Clínico Jefe de Residentes Hospital Churruca
Luciano Emilio Riera @LucianoRieraMD
5 Followers 63 Following Oncology Resident at Hospital Oncológico Provincial, Córdoba, Argentina 🇦🇷
Stanimir Dobrev @dobrev_stanimir
55 Followers 287 Following
Andrea Botticelli @DottBotticelliA
76 Followers 201 Following MD, PhD, assistant Professor, Sapienza University of Rome, breast cancer, Head and neck cancer, precision medicine @sapienzaroma
Adrien Mouren, MD @AMourenMD
61 Followers 395 Following Medical Oncologist @gustaveroussy 🏥 | Drug Development & Skin Cancer 🩺 | Passionate about Precision Medicine 🧬 | Travel & Language Lover 🌍 | Movie Buff 🎬
Yüksel Ürün @DrYukselUrun
6K Followers 574 Following Prof. Medical Oncologist 🔬 @AnkaraUni 🎓 Advocate for #Diversity & #Equity 🌟 Genitourinary Cancer I 2023-2024 @ASCO Leadership Development Program
Toni Choueiri, MD @DrChoueiri
36K Followers 479 Following Senior Executive & Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; 2021 Giants of Cancer Award ⚽ lover; 🚲@PanMass, seen on @msnbc @cnn @TODAYshow @GMA
Oncology Brothers @OncBrothers
12K Followers 414 Following Practice changing 🗣 by community oncologists: Rohit Gosain @RoswellPark & Rahul Gosain @WilmotCancer. OwnViews & not medical advice.COI https://t.co/cJOjp0RvQE
Paolo Tarantino @PTarantinoMD
22K Followers 536 Following Medical Oncologist, Research Fellow @DanaFarber | @Harvard | PhD @LaStatale. SoMe Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs & good music.
Deniz Can Guven @DenizCanGuven1
2K Followers 1K Following Medical Oncologist @myESMO Young Oncologist Committee Member Editorial Board Member in @BMC Cancer, @PLOSONE, @thePeerJ, and @OfOncological
ESMO - Eur. Oncology @myESMO
75K Followers 873 Following The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
Nazli Dizman @NazliDizman
8K Followers 6K Following MD & Researcher | Heme/Onc fellow @MDAndersonNews | @YaleIMed ‘23 | Postdoc @cityofhope @montypal | @ASCOTECAG | #WomenInMedicine | T/RT my own
Pashtoon Kasi MD, MS @pashtoonkasi
18K Followers 11K Following Oncologist | Researcher | ColorectalCancer #CRCSM👨🏼🎓@MayoClinic @PittTweet Alum; 🧬#ctDNA #LiquidBiopsies💡#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO23
Mark Lewis @marklewismd
88K Followers 39K Following Director, GI Oncology, @Intermountain. Interests: neuroendocrine tumors, cancer syndromes, empathy (even had a Whipple myself). Tweets my own.
Annals of Oncology @Annals_Oncology
47K Followers 520 Following Medical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.
Erika Hamilton, MD @ErikaHamilton9
15K Followers 3K Following Med Onc, Director of Breast Cancer Research Program @ Sarah Cannon Research Institute #bcsm #WomenInMedicine Wife, Mom to 2 girls, tweets are mine.
Dr Amol Akhade @SuyogCancer
3K Followers 122 Following Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists
Matteo Lambertini, MD.. @matteolambe
14K Followers 454 Following Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Chair of @myESMO YOC. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.
Doç.Dr.Erdinç Nayı.. @dronkoloji
9K Followers 2K Following Tıbbi Onkoloji Uzmanı / VM Medicalpark Mersin Hastanesi /Mail: [email protected]
Emre Yekedüz @yekeduz_emre
2K Followers 974 Following MD, Medical Oncologist I Research Fellow @DanaFarber_GU @Harvard | @ASCO #IMG CoP Comm Team Member| Assoc. Faculty @OncoAlert | Alumni @AnkaraUni @Hacettepe1967
Ibrahim Halil SAHIN, .. @IbrahimSahinMD1
3K Followers 733 Following GI Medical Oncologist | @UPMC Hillman CC/@PittTweet | NCI Colon Task Force | Clinical trialist-Colorectal Cancer| EO-CRC|musician-lead guitar| tweets=my own
Journal of Clinical O.. @JCO_ASCO
50K Followers 1K Following @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, & @JCOPO_ASCO.
Doç.Dr.Cengiz Karaç.. @KaracinCengiz
1K Followers 1K Following Türk Tıbbi Onkoloji Derneği Yönetim Kurulu Üyesi
Marta Perachino @MartaPerachino
440 Followers 242 Following MD | Medical Oncology Resident @ Policlinico San Martino ✈️ Research fellow @ Vall d’Hebron Institute of Oncology
Icro Meattini @Icro_Meattini
2K Followers 425 Following Professor, Florence University, Italy. Radiation/Clinical Oncologist. Head, Breast Unit at Florence Univ Hospital. Father. Opinions are my own. RT not endorse.
Eytan Ruppin, MD, PhD @NCIEytanRuppin
5K Followers 2K Following Chief, Cancer Data Science Laboratory, CCR/NCI | Computational biology, precision oncology, immunotherapy | Lab-run account Privacy: https://t.co/vMCvc3AIHE
FabriceAndre @FAndreMD
14K Followers 518 Following Head of Research Division of @GustaveRoussy , @myesmo President Elect
Dr Sarah Sammons @drsarahsam
4K Followers 1K Following Breast Medical Oncologist @dfci_breastonc. Harvard Medical School. Associate Director EMBRACE MBC Program. Tweets are NOT medical advice.
Harold J. Burstein, M.. @DrHBurstein
12K Followers 534 Following Breast cancer specialist and professor @DanaFarber Cancer Institute and @HarvardMed. Tweets are my own and not medical advice. COI disclosure: no COI.
Bartomeu Massuti @bmassutis
3K Followers 2K Following Born in Majorca. Medical oncologist. Clinical researcher. Focused in lung cancer. World citizen. Major concerns: human inequality and blue planet environment
Dr. Estela Rodriguez @Latinamd
6K Followers 3K Following Associate Director Community Outreach- DEI- 🫁Thoracic Oncology, University of Miami @SylvesterCancer , 🇵🇷Boricua, Co-founder @KidsHelpingKidsSucceed
Axel Grothey @agrothey
3K Followers 526 Following Passionate about justice & tolerance, teaching & educating oncologists, caring for cancer patients, learning from mistakes. Opinions and statements are my own.
Ben Solomon @bensolomon1
5K Followers 3K Following Lung cancer medical oncologist at Peter MacCallum Cancer Centre | Views are my own
Jeff Ryckman @jryckman3
4K Followers 3K Following Medical physicist➡️MD. Passionate about #RadOnc. Focus on QoL⚖️, LR-PFS 🎯, OS, constraints🙅♀️, standardization, & reproducibility. #RadOncCalc @RadOncReview
Santiesteban @s_santiesteban
583 Followers 1K Following Medical oncologist interested in breast cancer 🏥 Trained at @incmnszmx 🇲🇽
ayseehedef @ayseehedef
1 Followers 15 Following
Dr. Iván R. Gonzále.. @Dr_Ivanoncologo
4K Followers 5K Following Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.
Gil Morgan, MD @weoncologists
16K Followers 8K Following Clinical Oncologist from Texas🇺🇸Director of @OncoAlert 🚨 Proudly NIH, NCI & MDA trained. An ounce of prevention equals a pound of cure. Views are own🌏
brunolarvol.eth @brunolarvol
6K Followers 6K Following @LARVOL | 100 experts focused on onco data + AI | 50k cancer trials already digitized, 100k Kaplan Meier curves | free for non-commercial use, DM me
Enes Erul MD @ErulEnes
84 Followers 135 Following 🔬 Oncology Fellow @AnkaraUni 🏥 Dedicated to unraveling the complexities of cancer ✍️ Devoted reader 📚 #Oncology #MedTwitter🌟
MJosé Juan @mjuanfi81
828 Followers 956 Following
Antalya Hakkinda @AntalyaHakkinda
146K Followers 8 Following Antalya’nın en büyük medya platformu. Haber, reklam ve diğerleri için: [email protected] WhatsApp: 0544 100 07 23
Tejas Patil @TejasPatilMD
562 Followers 208 Following Thoracic oncologist @CUCancerCenter, via @Penn & @KeckMedUSC | Interests in #biomarkers & #PrecisionOncology in #lungcancer | Piano and ski on the side.
Serhat Sekmek @SerhatSekmek
679 Followers 397 Following Ankara Şehir Hastanesi Tıbbi Onkoloji. Hacettepe Dahiliye’20. HÜTF'15, FL 05-09, BEŞİKTAŞ
Onur Baş, MD @onur6191
114 Followers 128 Following Hacettepe University, Medical School, '16 Hacettepe University, Internal Medicine, '21 Hacettepe University, Medical Oncology '26
Ece Tolgay @ecetolgayy
424 Followers 745 Following Med Student👩🏻⚕️ @uludagkurumsal | Aspiring internist, medical oncologist 💊| Member of American Association of Immunologists @immunologyAAI #secondgen
Ibrahim Azar, MD @ibrahimazaronc
803 Followers 983 Following Medical Oncologist @IHACares Assistant Professor @WayneState. Alum @karmanoscancer @AlbanyMed @mcgillu. AΩA. GI Oncology Mednet Associate Editor.
Antalya Şehir Hastan.. @antalyasehirhst
109 Followers 22 Following Antalya Şehir Hastanesi Resmi Sayfasıdır. - Antalya City Hospital Official Page.
Mikhail V. Blagosklon.. @Blagosklonny
22K Followers 101 Following Professor of Oncology. Rapamycin for immortality. Author: Hyperfunction theory of mTOR-driven aging Editor-in-Chief: https://t.co/vOLFBqirGU & https://t.co/ivXaGJvXZo
Albert Vilella @AlbertVilella
21K Followers 8K Following Next-Generation Sequencing, Single-Cell and Spatial Biology, Next-Generation Proteomics, Synthetic Biology, Compute Acceleration in Biotech.
Burcu. @ulaskahyaB
144 Followers 488 Following Medical oncologist-in-training 🩺 PhD student in medical biology and genetics 🧬 #keeponsearching
Antalya İl Sağlık .. @antalyaism
2K Followers 121 Following Resmi X Hesabı Hüsnü Karakaş Mah. Hastane Cad. No:124 Kepez/ANTALYA Tel: 02423206000 E-posta: [email protected]
MarleenKokLab @lab_kok
2K Followers 500 Following medical oncologist, breast cancer immunotherapy investigator, mother, PI and associate prof at NKI, happy in Amsterdam
José Márcio Barros .. @josemarciofigu1
3K Followers 3K Following Oncologist with a focus on thoracic oncology and breast cancer, researcher, director of the Brazil Cancer Institute 🇧🇷
Markus Eckstein @Markuseckstein3
1K Followers 2K Following #Pathologist #Physician Scientist @UniFAU University Hospital Erlangen, Germany #pathology #biomarker_research - My opinions are my own
Luca Arecco, MD @Lucarecco
767 Followers 436 Following Medical Oncology Resident at @SanMartino_Ge @UniGenova🇮🇹 | Research Fellow @JulesBordet Institute 🇧🇪| Focused on Breast cancer |
Andrea Boutros @boutrosand
740 Followers 748 Following Medical Doctor & Oncology Resident @SanMartino_Ge & @MelanomaAus #Melanoma & Skin Cancer, Immunotherapy | 🇮🇹🇪🇬🇦🇺🇫🇷
Venky (Venkatraman Ra.. @venkymd
6K Followers 5K Following Medical Oncologist and Pediatric Oncologist.
Hagen Kennecke @HKennecke
1K Followers 439 Following GI and NET Oncologist, @OHSU Knight Cancer Institute, Chief & Med Dir CHO and Knight-Legacy Collaborative, Dad, cycling & ski enthusiast!
Andres F. Cardona @AndresFCardonaZ
8K Followers 4K Following Pursue knowledge, mentor students, collaborate globally, and push boundaries. Everything else is just noise in the academic concert.
Maite Bourlon @BourlonMaite
2K Followers 2K Following Oncology | Urologic Oncology @incmnszmx IDEA Award | Global Oncology TF @ASCO| Fellow @JCOGO_ASCO @oncofertilty LATAM @UPMex WWCC Award @ConquerCancerFd
ANTALYA BÜYÜKŞEHİ.. @ANTALYABB
363K Followers 23 Following Antalya Büyükşehir Belediyesi Resmi Twitter Sayfasıdır. ABB Başkanı (@BocekMuhittin)
Ulrike Harjes @UlrikeHarjes
1K Followers 1K Following Senior editor @NatureMedicine, handling oncology & immunology research manuscripts. Former editor @NatureRevCancer. Views are my own. Likes are just likes.
Willem Lybaert @WLybaert
450 Followers 653 Following Medisch Oncoloog VITAZ - UZA Belgium. Board member BSMO, Vice-President NETwerk ENETS CoE, Vice-President VWHHT.
Samuel Kareff, MD, MP.. @SamuelKareffMD
992 Followers 759 Following Chief Fellow @HemOncMiami (@SylvesterCancer+@JacksonHealth) Former #MedEd Chief @gtown_medres Tweets/likes ≠ medical advice | he/him | #LCSM |
Mustafa Erman @ermanm1968
69 Followers 116 Following
BMJ Oncology @BMJOncology
2K Followers 1K Following A new #OA journal from @bmj_company publishing across the broad spectrum of cancer research, investigation, treatment & practice. EIC: Prof Ananya Choudhury
Who better to answer the question about the relevance of HER2 low than @PTarantinoMD himself?
I understand this triumvirate is meeting only in countries with red+white flags 🇨🇭🇨🇦 ✈️Next can't be other than 🇳🇵!!
@dr_yakupergun @OncoAlert Promising T-DXd results for HER2+ cancer. Big leap for patient care & biotech. #HER2 #OncoProgress
@dr_yakupergun @OncoAlert Impressive ORR in HER2+ metastatic cases; safety concerns on ILD require debate. Valuable for precision oncology. @OncoAlert
@dr_yakupergun @OncoAlert IMO a good take home message is TDx works also if pts received antiHer2 therapy before. TDx seems a so special drug to me (no COI with Daichii)
Optimal dose . Cost of the tablet . Size of the tablet . Sotorasib dosing and Incremental Cost ineffectiveness. Does this ring bell 🔔 for other oral drugs also? Lorlatinib ? , lapatinib , Abemaciclib ?? , Abiraterone . Comment in @NatRevClinOncol by @garthstrohbehn and…
Young oncologists’ perspective on the role and future of the clinician-scientist in oncology. @ESMO_Open 📖 DOI 👉🏻 /10.1016/j.esmoop.2023.101625 #yo #esmo @myESMO
The importance of teaching how to do mentoring. In the LMICs, we need more clinician-scientists who get the basics, who create in the laboratory, who generate hypotheses with regional relevance, and who are willing to carry out applicable studies that respond to our needs. It is…
Young oncologists’ perspective on the role and future of the clinician-scientist in oncology. @ESMO_Open 📖 DOI 👉🏻 /10.1016/j.esmoop.2023.101625 #yo #esmo @myESMO
I am really happy to be one of the first authors of this article in @JournalofNucMed and have the oppurtunity to collect and analyse the data of patients received > 6 cycles of LuPSMA from different NM centers in Germany. Higlights: 🎯Favorable safety 🎯Maintained response
Treatment landscape for resectable NSCLS is quickly changing. Discussion/group effort by led @ASridharMD @IvyLorena_Md @ArpanAshokPatel to reiterate the current SoC! @FordePatrick thank you for ICER table! 🙏🏽🙏🏽 #lcsm #ASCODailyNews @ASCO #OncTwitter #ASCO24 #MedTwitter
Out in @Nature_NPJ Breast a post-hoc subgroup analysis of ASCENT to evaluate activity of sacituzumab govitecan in subgroups of poor prognosis👵🏻👩🏾🦱🧠 SG ⬆️ outcomes vs. TPC in pts⬆️65y.o., in black pts but not significantly in brain mets pts @OncoAlert nature.com/articles/s4152…
TNBC Brain Mets are a HUGE unmet need. They occur in 1/3 mTNBC pts and most events after pCR/RCB1 are CNS. Sacituzumab is not the answer. Median PFS for SG vs TPC was 2.8 vs 1.6 months (HR 0.68; 95% CI 0.38–1.23). OS not improved. Hoping other ADCs will do better. #bcsm
Out in @Nature_NPJ Breast a post-hoc subgroup analysis of ASCENT to evaluate activity of sacituzumab govitecan in subgroups of poor prognosis👵🏻👩🏾🦱🧠 SG ⬆️ outcomes vs. TPC in pts⬆️65y.o., in black pts but not significantly in brain mets pts @OncoAlert nature.com/articles/s4152…
Study reveals that most patients with advanced urothelial carcinoma in the US🇺🇸do not progress beyond 1⃣st-line treatment ➡️Highlighting the need for more effective and tolerable initial therapies
Just Out🚨 on @JAMANetworkOpen Study reveals that most patients with advanced urothelial carcinoma in the US do not progress beyond 1⃣st-line treatment ➡️Highlighting the need for more effective and tolerable initial therapies🧪 jamanetwork.com/journals/jaman… @vinay_onc @TripNish…
After 3 years of hard work, against all odds and despite many barriers along the way, I am happy to share that I have graduated from the Duke/NIH clinical research training program through the Duke School of Medicine!! Dreams do come true! I am officially Tarek Haykal, MD, MHS!!
So what's in store for lung cancer at #asco24 @ASCO Apart from Laura and Adriatic which are plenary sessions We have some interesting data coming up #LCSM 1 - will Sacituzumab Govitecan be better than Docetaxel in second line NSCLC? EVOKE -01 study . 2 - will addition of…
So stage is set for battle of decade Flot vs Cross -Esopec trial as plenary session for #asco24 @ASCO . Along with Laura and Adriatic for NSCLC and SCLC respectively . Nice to see ealry palliative care by telehealth into asco plenary. @dr_yakupergun @DrYukselUrun @GlopesMd…
The OncoAlert🚨NEWSLETTER OUT Covering April 25 to May 1, 2024 REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…
The OncoAlert🚨NEWSLETTER OUT Covering April 25 to May 1, 2024 REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… COVERING ✅DESTINY-Breast06 astrazeneca.com/media-centre/p… ✅Monarch E🦋 nature.com/articles/s4152… ✅ US Preventive S Task force #BreastCancer Screen…
⚡️ Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US #BladderCancer @vinay_onc @umangtalking @neerajaiims @OncoAlert @JAMANetworkOpen jamanetwork.com/journals/jaman…
This excellent review on estrogen receptor alpha mutations, truncations, heterodimers, and therapies, goes into the history of ERα, current research unlocking unknown aspects of ERα signaling, and future directions of ESR1 investigation @RMJesel @GertzLab pubmed.ncbi.nlm.nih.gov/38643482/
Just Out🚨 on @JAMANetworkOpen Study reveals that most patients with advanced urothelial carcinoma in the US do not progress beyond 1⃣st-line treatment ➡️Highlighting the need for more effective and tolerable initial therapies🧪 jamanetwork.com/journals/jaman… @vinay_onc @TripNish…
Trends for United States
You might like
